The Food and Drug Administration inspected American National Red Cross in Rockville on Feb. 12, reviewing operations involving blood and blood products, according to information posted on the FDA’s website.
The inspection’s final summary found that American National Red Cross did not require corrective actions regarding its management practices.
The FDA conducts regular inspections of facilities nationwide to ensure compliance with public health regulations. Outcomes from these visits are posted for public review.
The FDA’s website notes that the agency is mainly tasked with overseeing the manufacturing and distribution of human and animal drugs, biologic products, medical supplies, and tobacco items to maintain safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
